25 XP   0   0   10

Morepen Laboratories Limited
Buy, Hold or Sell?

Let's analyse Morepen together

PenkeI guess you are interested in Morepen Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Morepen Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Morepen Laboratories Limited

I send you an email if I find something interesting about Morepen Laboratories Limited.

Quick analysis of Morepen (30 sec.)










What can you expect buying and holding a share of Morepen? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
INR14.72
Expected worth in 1 year
INR29.12
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
INR14.40
Return On Investment
28.1%

For what price can you sell your share?

Current Price per Share
INR51.15
Expected price per share
INR41.30 - INR56.40
How sure are you?
50%

1. Valuation of Morepen (5 min.)




Live pricePrice per Share (EOD)

INR51.15

Intrinsic Value Per Share

INR-43.58 - INR-3.04

Total Value Per Share

INR-28.86 - INR11.68

2. Growth of Morepen (5 min.)




Is Morepen growing?

Current yearPrevious yearGrowGrow %
How rich?$90.2m$69.3m$20.9m23.2%

How much money is Morepen making?

Current yearPrevious yearGrowGrow %
Making money$4.6m$12.2m-$7.5m-162.9%
Net Profit Margin2.7%6.6%--

How much money comes from the company's main activities?

3. Financial Health of Morepen (5 min.)




What can you expect buying and holding a share of Morepen? (5 min.)

Welcome investor! Morepen's management wants to use your money to grow the business. In return you get a share of Morepen.

What can you expect buying and holding a share of Morepen?

First you should know what it really means to hold a share of Morepen. And how you can make/lose money.

Speculation

The Price per Share of Morepen is INR51.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Morepen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Morepen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR14.72. Based on the TTM, the Book Value Change Per Share is INR3.60 per quarter. Based on the YOY, the Book Value Change Per Share is INR2.82 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Morepen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.010.0%0.010.0%0.020.0%0.010.0%0.010.0%
Usd Book Value Change Per Share0.040.1%0.040.1%0.030.1%0.020.0%0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.040.1%0.040.1%0.030.1%0.020.0%0.010.0%
Usd Price Per Share0.31-0.31-0.44-0.29-0.26-
Price to Earnings Ratio34.10-34.10-18.69-22.96-52.30-
Price-to-Total Gains Ratio7.17-7.17-12.96-15.83-7.29-
Price to Book Ratio1.75-1.75-3.29-2.82-3.13-
Price-to-Total Gains Ratio7.17-7.17-12.96-15.83-7.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.6138
Number of shares1629
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.040.02
Usd Total Gains Per Share0.040.02
Gains per Quarter (1629 shares)70.3640.42
Gains per Year (1629 shares)281.42161.67
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102812710161152
205635521322314
308448331484476
40112611142645638
50140713952806800
60168916763967962
7019701957311291124
8022512238412901286
9025332519414511448
10028142800516121610

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%9.01.00.090.0%9.08.00.052.9%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.03.00.070.0%10.07.00.058.8%
Dividend per Share0.00.01.00.0%1.00.02.033.3%3.00.02.060.0%6.00.04.060.0%6.00.011.035.3%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.03.00.070.0%10.07.00.058.8%

Fundamentals of Morepen

About Morepen Laboratories Limited

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-gout, anti-depressant, and anti-malarial drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides fever X for fever; Pain X for pain; Fiber-X, a sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Fundamental data was last updated by Penke on 2024-04-14 04:55:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Morepen Laboratories Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Morepen earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 2.7% means that ₹0.03 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Morepen Laboratories Limited:

  • The MRQ is 2.7%. The company is making a profit. +1
  • The TTM is 2.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.7%TTM2.7%0.0%
TTM2.7%YOY6.6%-3.9%
TTM2.7%5Y5.2%-2.5%
5Y5.2%10Y3.7%+1.5%
1.1.2. Return on Assets

Shows how efficient Morepen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.5% Return on Assets means that Morepen generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Morepen Laboratories Limited:

  • The MRQ is 3.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.5%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.5%TTM3.5%0.0%
TTM3.5%YOY9.5%-6.0%
TTM3.5%5Y7.0%-3.5%
5Y7.0%10Y4.7%+2.3%
1.1.3. Return on Equity

Shows how efficient Morepen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.1% Return on Equity means Morepen generated ₹0.05 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Morepen Laboratories Limited:

  • The MRQ is 5.1%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.1%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.1%TTM5.1%0.0%
TTM5.1%YOY17.6%-12.4%
TTM5.1%5Y14.1%-9.0%
5Y14.1%10Y9.5%+4.6%

1.2. Operating Efficiency of Morepen Laboratories Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Morepen is operating .

  • Measures how much profit Morepen makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 4.1% means the company generated ₹0.04  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Morepen Laboratories Limited:

  • The MRQ is 4.1%. The company is operating less efficient.
  • The TTM is 4.1%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ4.1%TTM4.1%0.0%
TTM4.1%YOY8.4%-4.3%
TTM4.1%5Y6.0%-1.9%
5Y6.0%10Y5.0%+1.0%
1.2.2. Operating Ratio

Measures how efficient Morepen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.96 means that the operating costs are ₹0.96 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Morepen Laboratories Limited:

  • The MRQ is 0.964. The company is less efficient in keeping operating costs low.
  • The TTM is 0.964. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.964TTM0.9640.000
TTM0.964YOY0.929+0.034
TTM0.9645Y0.949+0.015
5Y0.94910Y0.955-0.006

1.3. Liquidity of Morepen Laboratories Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Morepen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.35 means the company has ₹2.35 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Morepen Laboratories Limited:

  • The MRQ is 2.354. The company is able to pay all its short-term debts. +1
  • The TTM is 2.354. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.354TTM2.3540.000
TTM2.354YOY1.609+0.746
TTM2.3545Y1.442+0.913
5Y1.44210Y1.186+0.256
1.3.2. Quick Ratio

Measures if Morepen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.14 means the company can pay off ₹1.14 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Morepen Laboratories Limited:

  • The MRQ is 1.138. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.138. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.138TTM1.1380.000
TTM1.138YOY1.082+0.056
TTM1.1385Y0.800+0.339
5Y0.80010Y0.655+0.144

1.4. Solvency of Morepen Laboratories Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Morepen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Morepen to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.32 means that Morepen assets are financed with 32.2% credit (debt) and the remaining percentage (100% - 32.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Morepen Laboratories Limited:

  • The MRQ is 0.322. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.322. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.322TTM0.3220.000
TTM0.322YOY0.460-0.137
TTM0.3225Y0.490-0.168
5Y0.49010Y0.470+0.020
1.4.2. Debt to Equity Ratio

Measures if Morepen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 47.6% means that company has ₹0.48 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Morepen Laboratories Limited:

  • The MRQ is 0.476. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.476. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.476TTM0.4760.000
TTM0.476YOY0.850-0.375
TTM0.4765Y1.023-0.548
5Y1.02310Y0.947+0.076

2. Market Valuation of Morepen Laboratories Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Morepen generates.

  • Above 15 is considered overpriced but always compare Morepen to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 34.10 means the investor is paying ₹34.10 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Morepen Laboratories Limited:

  • The EOD is 67.605. Based on the earnings, the company is expensive. -2
  • The MRQ is 34.100. Based on the earnings, the company is overpriced. -1
  • The TTM is 34.100. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD67.605MRQ34.100+33.505
MRQ34.100TTM34.1000.000
TTM34.100YOY18.685+15.415
TTM34.1005Y22.958+11.142
5Y22.95810Y52.304-29.346
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Morepen Laboratories Limited:

  • The EOD is -19.065. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.616. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.616. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.065MRQ-9.616-9.449
MRQ-9.616TTM-9.6160.000
TTM-9.616YOY-15.184+5.568
TTM-9.6165Y42.249-51.865
5Y42.24910Y32.555+9.694
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Morepen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 1.75 means the investor is paying ₹1.75 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Morepen Laboratories Limited:

  • The EOD is 3.475. Based on the equity, the company is fair priced.
  • The MRQ is 1.753. Based on the equity, the company is underpriced. +1
  • The TTM is 1.753. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.475MRQ1.753+1.722
MRQ1.753TTM1.7530.000
TTM1.753YOY3.287-1.534
TTM1.7535Y2.824-1.071
5Y2.82410Y3.131-0.308
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Morepen Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--3.5993.5990%2.821+28%2.062+75%0.886+306%
Book Value Per Share--14.72014.7200%11.121+32%8.926+65%7.265+103%
Current Ratio--2.3542.3540%1.609+46%1.442+63%1.186+99%
Debt To Asset Ratio--0.3220.3220%0.460-30%0.490-34%0.470-31%
Debt To Equity Ratio--0.4760.4760%0.850-44%1.023-54%0.947-50%
Dividend Per Share----0%-0%0.006-100%0.006-100%
Eps--0.7570.7570%1.956-61%1.167-35%0.711+6%
Free Cash Flow Per Share---2.683-2.6830%-2.407-10%-0.979-64%-0.088-97%
Free Cash Flow To Equity Per Share--0.1250.1250%-1.179+1041%0.033+282%0.104+20%
Gross Profit Margin---1.405-1.4050%0.473-397%-0.123-91%0.187-852%
Intrinsic Value_10Y_max---3.040--------
Intrinsic Value_10Y_min---43.585--------
Intrinsic Value_1Y_max---0.135--------
Intrinsic Value_1Y_min---2.343--------
Intrinsic Value_3Y_max---0.535--------
Intrinsic Value_3Y_min---8.835--------
Intrinsic Value_5Y_max---1.091--------
Intrinsic Value_5Y_min---17.244--------
Market Cap26146293940.800+50%13188159993.60013188159993.6000%18999647683.100-31%12459132261.100+6%10906762407.350+21%
Net Profit Margin--0.0270.0270%0.066-59%0.052-48%0.037-27%
Operating Margin--0.0410.0410%0.084-51%0.060-32%0.050-19%
Operating Ratio--0.9640.9640%0.929+4%0.949+2%0.955+1%
Pb Ratio3.475+50%1.7531.7530%3.287-47%2.824-38%3.131-44%
Pe Ratio67.605+50%34.10034.1000%18.685+82%22.958+49%52.304-35%
Price Per Share51.150+50%25.80025.8000%36.550-29%24.250+6%21.275+21%
Price To Free Cash Flow Ratio-19.065-98%-9.616-9.6160%-15.184+58%42.249-123%32.555-130%
Price To Total Gains Ratio14.212+50%7.1687.1680%12.958-45%15.834-55%7.294-2%
Quick Ratio--1.1381.1380%1.082+5%0.800+42%0.655+74%
Return On Assets--0.0350.0350%0.095-63%0.070-50%0.047-25%
Return On Equity--0.0510.0510%0.176-71%0.141-64%0.095-46%
Total Gains Per Share--3.5993.5990%2.821+28%2.068+74%0.892+304%
Usd Book Value--90293724.00090293724.0000%69372060.000+30%54985586.400+64%44678226.000+102%
Usd Book Value Change Per Share--0.0430.0430%0.034+28%0.025+75%0.011+306%
Usd Book Value Per Share--0.1770.1770%0.133+32%0.107+65%0.087+103%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Eps--0.0090.0090%0.023-61%0.014-35%0.009+6%
Usd Free Cash Flow---16457112.000-16457112.0000%-15015072.000-9%-6056592.000-63%-565964.400-97%
Usd Free Cash Flow Per Share---0.032-0.0320%-0.029-10%-0.012-64%-0.001-97%
Usd Free Cash Flow To Equity Per Share--0.0020.0020%-0.014+1041%0.000+282%0.001+20%
Usd Market Cap313755527.290+50%158257919.923158257919.9230%227995772.197-31%149509587.133+6%130881148.888+21%
Usd Price Per Share0.614+50%0.3100.3100%0.439-29%0.291+6%0.255+21%
Usd Profit--4641024.0004641024.0000%12201924.000-62%7310452.800-37%4438813.200+5%
Usd Revenue--170103600.000170103600.0000%184987800.000-8%137526703.200+24%97974055.200+74%
Usd Total Gains Per Share--0.0430.0430%0.034+28%0.025+74%0.011+304%
 EOD+5 -3MRQTTM+0 -0YOY+15 -195Y+19 -1710Y+23 -13

3.2. Fundamental Score

Let's check the fundamental score of Morepen Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1567.605
Price to Book Ratio (EOD)Between0-13.475
Net Profit Margin (MRQ)Greater than00.027
Operating Margin (MRQ)Greater than00.041
Quick Ratio (MRQ)Greater than11.138
Current Ratio (MRQ)Greater than12.354
Debt to Asset Ratio (MRQ)Less than10.322
Debt to Equity Ratio (MRQ)Less than10.476
Return on Equity (MRQ)Greater than0.150.051
Return on Assets (MRQ)Greater than0.050.035
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Morepen Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.528
Ma 20Greater thanMa 5046.723
Ma 50Greater thanMa 10047.551
Ma 100Greater thanMa 20047.740
OpenGreater thanClose51.800
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
Total Other Income Expense Net 15,6186,44322,061-18,6003,46183,49386,954-90,188-3,234



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets11,104,951
Total Liabilities3,580,474
Total Stockholder Equity7,529,081
 As reported
Total Liabilities 3,580,474
Total Stockholder Equity+ 7,529,081
Total Assets = 11,104,951

Assets

Total Assets11,104,951
Total Current Assets7,561,647
Long-term Assets3,543,304
Total Current Assets
Cash And Cash Equivalents 216,658
Short-term Investments 401,524
Net Receivables 2,635,207
Inventory 2,288,863
Other Current Assets 2,019,395
Total Current Assets  (as reported)7,561,647
Total Current Assets  (calculated)7,561,647
+/-0
Long-term Assets
Property Plant Equipment 1,840,127
Goodwill 744,742
Intangible Assets 254,986
Other Assets 639,177
Long-term Assets  (as reported)3,543,304
Long-term Assets  (calculated)3,479,032
+/- 64,272

Liabilities & Shareholders' Equity

Total Current Liabilities3,211,631
Long-term Liabilities368,843
Total Stockholder Equity7,529,081
Total Current Liabilities
Short-term Debt 242,306
Short Long Term Debt 242,306
Accounts payable 2,268,793
Other Current Liabilities 36,857
Total Current Liabilities  (as reported)3,211,631
Total Current Liabilities  (calculated)2,790,262
+/- 421,369
Long-term Liabilities
Long term Debt Total 9,335
Other Liabilities 359,508
Long-term Liabilities  (as reported)368,843
Long-term Liabilities  (calculated)368,843
+/-0
Total Stockholder Equity
Common Stock1,022,271
Retained Earnings 1,900,120
Accumulated Other Comprehensive Income 908,804
Capital Surplus 3,697,886
Total Stockholder Equity (as reported)7,529,081
Total Stockholder Equity (calculated)7,529,081
+/-0
Other
Capital Stock1,022,271
Cash and Short Term Investments 618,182
Common Stock Shares Outstanding 502,207
Current Deferred Revenue663,675
Liabilities and Stockholders Equity 11,104,951
Net Debt 34,983
Net Invested Capital 7,780,722
Net Tangible Assets 6,529,353
Net Working Capital 4,350,016
Property Plant and Equipment Gross 1,840,127
Short Long Term Debt Total 251,641



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-31
> Total Assets 
12,115,916
11,616,800
7,125,683
6,773,444
6,901,580
5,469,800
5,060,900
4,895,000
4,890,000
5,236,843
5,383,137
5,858,064
6,151,774
6,634,639
8,581,460
10,700,527
11,104,951
11,104,95110,700,5278,581,4606,634,6396,151,7745,858,0645,383,1375,236,8434,890,0004,895,0005,060,9005,469,8006,901,5806,773,4447,125,68311,616,80012,115,916
   > Total Current Assets 
1,092,501
597,861
646,506
699,564
801,292
896,100
910,900
1,195,800
1,145,800
1,571,509
1,921,681
2,471,286
2,994,684
3,721,765
5,267,910
7,343,011
7,561,647
7,561,6477,343,0115,267,9103,721,7652,994,6842,471,2861,921,6811,571,5091,145,8001,195,800910,900896,100801,292699,564646,506597,8611,092,501
       Cash And Cash Equivalents 
682,565
152,718
45,875
11,029
25,818
45,100
55,300
91,100
88,500
43,614
75,911
57,161
95,951
136,391
413,869
158,026
216,658
216,658158,026413,869136,39195,95157,16175,91143,61488,50091,10055,30045,10025,81811,02945,875152,718682,565
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
2,178
225
249,803
270,893
352,309
401,524
401,524352,309270,893249,8032252,17800000000000
       Net Receivables 
0
0
0
0
0
0
0
466,600
599,449
880,107
1,019,064
1,271,460
1,838,658
1,439,295
2,093,479
4,426,445
2,635,207
2,635,2074,426,4452,093,4791,439,2951,838,6581,271,4601,019,064880,107599,449466,6000000000
       Inventory 
180,812
190,907
222,939
316,842
347,073
386,600
370,500
333,000
371,100
421,418
646,649
768,869
942,016
1,384,757
1,753,257
2,758,541
2,288,863
2,288,8632,758,5411,753,2571,384,757942,016768,869646,649421,418371,100333,000370,500386,600347,073316,842222,939190,907180,812
       Other Current Assets 
229,124
254,236
377,692
371,693
428,401
464,400
485,100
771,700
686,200
1,106,477
1,199,121
1,643,078
117,834
2,200,617
1,007,305
-1
2,019,395
2,019,395-11,007,3052,200,617117,8341,643,0781,199,1211,106,477686,200771,700485,100464,400428,401371,693377,692254,236229,124
   > Long-term Assets 
11,023,415
11,018,939
6,479,177
6,073,880
6,100,288
4,573,700
4,150,000
3,699,200
3,744,200
3,665,334
3,461,456
3,386,778
3,157,090
2,912,874
3,313,550
3,357,516
3,543,304
3,543,3043,357,5163,313,5502,912,8743,157,0903,386,7783,461,4563,665,3343,744,2003,699,2004,150,0004,573,7006,100,2886,073,8806,479,17711,018,93911,023,415
       Property Plant Equipment 
6,857,628
6,380,008
5,834,398
5,401,812
4,960,163
3,739,200
3,312,000
2,895,500
2,440,400
2,183,018
1,937,569
1,723,967
1,473,671
1,340,894
1,312,415
1,607,929
1,840,127
1,840,1271,607,9291,312,4151,340,8941,473,6711,723,9671,937,5692,183,0182,440,4002,895,5003,312,0003,739,2004,960,1635,401,8125,834,3986,380,0086,857,628
       Goodwill 
0
0
0
0
0
0
0
779,400
779,391
779,664
779,608
744,854
744,798
744,742
744,742
744,742
744,742
744,742744,742744,742744,742744,798744,854779,608779,664779,391779,4000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
5,864
0
0
0
0
0
0
0000005,8640000000000
       Intangible Assets 
0
0
0
0
0
0
0
5,900
5,017
4,478
4,283
176,677
146,159
80,616
210,188
309,338
254,986
254,986309,338210,18880,616146,159176,6774,2834,4785,0175,9000000000
       Long-term Assets Other 
4,165,787
4,638,931
644,779
672,068
1,140,125
834,500
838,000
803,700
1,303,800
1,482,316
1,523,887
741,280
792,462
-10
1,037,284
603,094
639,177
639,177603,0941,037,284-10792,462741,2801,523,8871,482,3161,303,800803,700838,000834,5001,140,125672,068644,7794,638,9314,165,787
> Total Liabilities 
5,709,551
3,654,537
3,613,276
2,249,787
2,377,924
2,270,000
2,066,400
1,927,900
2,019,200
2,240,300
2,151,260
3,603,190
3,625,477
3,798,662
4,338,555
4,919,522
3,580,474
3,580,4744,919,5224,338,5553,798,6623,625,4773,603,1902,151,2602,240,3002,019,2001,927,9002,066,4002,270,0002,377,9242,249,7873,613,2763,654,5375,709,551
   > Total Current Liabilities 
725,622
731,310
808,737
852,392
957,466
1,058,600
1,027,300
1,081,400
1,279,200
1,665,606
1,973,257
3,401,214
3,391,699
3,514,436
4,038,000
4,564,569
3,211,631
3,211,6314,564,5694,038,0003,514,4363,391,6993,401,2141,973,2571,665,6061,279,2001,081,4001,027,3001,058,600957,466852,392808,737731,310725,622
       Short-term Debt 
0
0
0
0
0
0
0
11,900
22,300
240,942
488,285
116,170
101,147
125,435
162,174
172,479
242,306
242,306172,479162,174125,435101,147116,170488,285240,94222,30011,9000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
892,800
163,863
240,942
488,285
205,851
101,147
125,435
153,244
172,479
242,306
242,306172,479153,244125,435101,147205,851488,285240,942163,863892,8000000000
       Accounts payable 
0
0
0
0
0
649,800
568,100
686,000
849,600
4,267
1,248,254
1,748,845
1,681,502
1,723,043
2,088,489
2,581,156
2,268,793
2,268,7932,581,1562,088,4891,723,0431,681,5021,748,8451,248,2544,267849,600686,000568,100649,80000000
       Other Current Liabilities 
725,622
731,310
808,737
852,392
957,466
408,800
459,200
383,500
407,300
1,661,339
220,342
1,525,452
1,557,680
43,500
5,806
5,786
36,857
36,8575,7865,80643,5001,557,6801,525,452220,3421,661,339407,300383,500459,200408,800957,466852,392808,737731,310725,622
   > Long-term Liabilities 
4,983,929
2,923,227
2,804,539
1,397,395
1,420,458
1,211,400
1,039,100
846,500
740,000
574,694
178,003
201,976
233,778
284,226
300,555
354,953
368,843
368,843354,953300,555284,226233,778201,976178,003574,694740,000846,5001,039,1001,211,4001,420,4581,397,3952,804,5392,923,2274,983,929
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
510,613
13,834
29,473
18,292
9,246
8,283
13,211
9,335
9,33513,2118,2839,24618,29229,47313,834510,613000000000
       Other Liabilities 
0
0
0
0
0
0
0
98,700
117,275
140,581
164,169
172,503
215,486
274,980
292,272
341,742
359,508
359,508341,742292,272274,980215,486172,503164,169140,581117,27598,7000000000
> Total Stockholder Equity
6,406,364
7,962,262
3,512,406
4,523,656
4,523,656
3,204,000
2,998,800
2,971,100
2,874,800
3,002,835
3,238,214
2,259,416
2,530,928
2,840,611
4,247,498
5,785,612
7,529,081
7,529,0815,785,6124,247,4982,840,6112,530,9282,259,4163,238,2143,002,8352,874,8002,971,1002,998,8003,204,0004,523,6564,523,6563,512,4067,962,2626,406,364
   Common Stock
2,015,592
1,938,166
1,938,166
2,096,107
2,096,107
2,096,100
2,096,100
2,096,100
2,096,100
2,096,106
2,096,106
899,586
899,586
899,586
899,586
955,586
1,022,271
1,022,271955,586899,586899,586899,586899,5862,096,1062,096,1062,096,1002,096,1002,096,1002,096,1002,096,1072,096,1071,938,1661,938,1662,015,592
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 
-3,165,691
-3,650,527
-4,078,750
-4,553,547
-5,019,360
-5,222,900
-5,677,100
-6,131,000
-6,632,000
-6,977,471
-7,308,963
-7,060,058
-6,178,621
-4,955,291
1,127,319
998,607
908,804
908,804998,6071,127,319-4,955,291-6,178,621-7,060,058-7,308,963-6,977,471-6,632,000-6,131,000-5,677,100-5,222,900-5,019,360-4,553,547-4,078,750-3,650,527-3,165,691
   Capital Surplus 
0
0
0
0
0
0
0
0
0
1,674,051
1,674,051
1,674,051
1,674,051
1,674,051
1,674,051
2,318,051
3,697,886
3,697,8862,318,0511,674,0511,674,0511,674,0511,674,0511,674,0511,674,051000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
7,556,463
9,674,623
5,652,990
6,981,096
7,446,909
7,650,400
8,090,500
8,544,400
9,045,400
9,390,895
9,722,387
9,468,490
8,570,072
-475,269
-1,446,128
-2,468,954
-2,922,391
-2,922,391-2,468,954-1,446,128-475,2698,570,0729,468,4909,722,3879,390,8959,045,4008,544,4008,090,5007,650,4007,446,9096,981,0965,652,9909,674,6237,556,463



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue14,175,300
Cost of Revenue-9,557,444
Gross Profit4,617,8564,617,856
 
Operating Income (+$)
Gross Profit4,617,856
Operating Expense-4,101,829
Operating Income560,787516,027
 
Operating Expense (+$)
Research Development30,689
Selling General Administrative141,622
Selling And Marketing Expenses930,136
Operating Expense4,101,8291,102,447
 
Net Interest Income (+$)
Interest Income19,808
Interest Expense-19,808
Other Finance Cost-19,808
Net Interest Income-19,808
 
Pretax Income (+$)
Operating Income560,787
Net Interest Income-19,808
Other Non-Operating Income Expenses0
Income Before Tax (EBT)557,553564,021
EBIT - interestExpense = 557,553
557,550
406,560
Interest Expense19,808
Earnings Before Interest and Taxes (EBIT)577,361577,361
Earnings Before Interest and Taxes (EBITDA)856,665
 
After tax Income (+$)
Income Before Tax557,553
Tax Provision-170,798
Net Income From Continuing Ops386,755386,755
Net Income386,752
Net Income Applicable To Common Shares386,752
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,659,273
Total Other Income/Expenses Net-3,23419,808
 

Technical Analysis of Morepen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Morepen. The general trend of Morepen is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Morepen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Morepen Laboratories Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 56.30 < 56.40.

The bearish price targets are: 49.20 > 43.05 > 41.30.

Tweet this
Morepen Laboratories Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Morepen Laboratories Limited. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Morepen Laboratories Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Morepen Laboratories Limited. The current macd is 1.15575996.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Morepen price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Morepen. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Morepen price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Morepen Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) ChartMorepen Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Morepen Laboratories Limited. The current adx is 18.93.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Morepen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Morepen Laboratories Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Morepen Laboratories Limited. The current sar is 44.09.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Morepen Laboratories Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Morepen Laboratories Limited. The current rsi is 63.53. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Morepen Laboratories Limited Daily Relative Strength Index (RSI) ChartMorepen Laboratories Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Morepen Laboratories Limited. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Morepen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Morepen Laboratories Limited Daily Stochastic Oscillator ChartMorepen Laboratories Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Morepen Laboratories Limited. The current cci is 150.35.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Morepen Laboratories Limited Daily Commodity Channel Index (CCI) ChartMorepen Laboratories Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Morepen Laboratories Limited. The current cmo is 37.96.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Morepen Laboratories Limited Daily Chande Momentum Oscillator (CMO) ChartMorepen Laboratories Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Morepen Laboratories Limited. The current willr is -19.8019802.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Morepen Laboratories Limited Daily Williams %R ChartMorepen Laboratories Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Morepen Laboratories Limited.

Morepen Laboratories Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Morepen Laboratories Limited. The current atr is 2.27592463.

Morepen Laboratories Limited Daily Average True Range (ATR) ChartMorepen Laboratories Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Morepen Laboratories Limited. The current obv is 455,152,082.

Morepen Laboratories Limited Daily On-Balance Volume (OBV) ChartMorepen Laboratories Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Morepen Laboratories Limited. The current mfi is 71.64.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Morepen Laboratories Limited Daily Money Flow Index (MFI) ChartMorepen Laboratories Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Morepen Laboratories Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-08CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Morepen Laboratories Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Morepen Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5063.528
Ma 20Greater thanMa 5046.723
Ma 50Greater thanMa 10047.551
Ma 100Greater thanMa 20047.740
OpenGreater thanClose51.800
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Morepen with someone you think should read this too:
  • Are you bullish or bearish on Morepen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Morepen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Morepen Laboratories Limited

I send you an email if I find something interesting about Morepen Laboratories Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Morepen Laboratories Limited.

Receive notifications about Morepen Laboratories Limited in your mailbox!